Post
Yuvi.
$LLY，昨日retatrutide头对头数据是否足以改变竞争格局？公司称试验中其减重效果超过Ozempic最高获批剂量两倍，且今天有Q3业绩电话会。临床结果可增强管线预期，但安全性、完整终点和产能仍决定商业转化。若详细数据稳健、供给扩张兑现，判断更积极；若耐受性或生产限制显现，我会下调峰值预期。
Disclaimer: OKX Orbit content is provided for informational purposes only. Learn more
Replies
No comments yet. Be the first to reply!
Trending crypto
BTC/USDTBitcoin
$73,895.6+0.01%
ETH/USDTEthereum
$2,059.36+0.02%
SOL/USDTSolana
$83.75+0.02%
Today’s market buzz
1#After the US October CPI exceeded expectations, AI stocks and crypto trends diverged
2#Goldman Sachs predicts Anthropic's revenue will exceed $600 billion by 2030
3#NebiusAI cloud business rapid growth faces earnings report test
